Interleukin 18 participates in the early inflammatory response and bacterial clearance during pneumonia caused by nontypeable Haemophilus influenzae

Infection and Immunity

Volumn 75, Issue 10, 2007, Pages 5068-5072

  Wieland, Catharina W ^a,b,d   Florquin, Sandrine ^c   Van Der Poll, Tom ^a,b  

^a Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^b Center of Experimental and Molecular Medicine (CEMM)   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEARANCE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; WILD TYPE;

ANIMALS; CHEMOKINES; COLONY COUNT, MICROBIAL; CYTOKINES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; INTERLEUKIN-18; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PNEUMONIA, BACTERIAL;

EID: 34848900121     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00287-07     Document Type: Article

References (19)

1. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
2. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
3. Branger, J., C. W. Wieland, S. Florquin, N. A. Maris, J. M. Pater, P. Speelman, T. Shimizu, S. Ishii, and T. van der Poll. 2004. Platelet-activating factor receptor-deficient mice show an unaltered clearance of nontypeable Haemophilus influenzae from their respiratory tract. Shock 22:543-547.
4. Campbell, G. D., Jr. 1999. Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia. Chest 115:14S-18S.
5. Drenth, J. P., and J. W. van der Meer. 2006. The inflammasome - a line-backer of innate defense. N. Engl. J. Med. 355:730-732.
6. Knapp, S., M. J. Schultz, and T. Poll. 2005. Pneumonia models and innate immunity to respiratory bacterial pathogens. Shock 24(Suppl. 1):12-18.
7. Knapp, S., C. W. Wieland, C. van 't Veer, O. Takeuchi, S. Akira, S. Florquin, and T. van der Poll. 2004. Toll-like receptor 2 plays a role in the early immune response to murine pneumococcal pneumonia but does not contribute to antibacterial host defense. J. Immunol. 172:3132-3138.
8. Lauw, F. N., J. Branger, S. Florquin, P. Speelman, S. J. van Deventer, S. Akira, and T. van der Poll. 2002. IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol. 168:372-378.
9. Maris, N. A., S. Florquin, C. van't Veer, A. F. de Vos, W. Buurman, H. M. Jansen, and T. van der Poll. 2006. Inhalation of beta 2 agonists impairs the clearance of nontypable Haemophilus influenzae from the murine respiratory tract. Respir. Res. 7:57.
10. Maris, N. A., K. F. van der Sluijs, S. Florquin, A. F. de Vos, J. M. Pater, H. M. Jansen, and T. van der Poll. 2004. Salmeterol, a β2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L1122-L1128.
11. Ogura, Y., F. S. Sutterwala, and R. A. Flavell. 2006. The inflammasome: first line of the immune response to cell stress. Cell 126:659-662.
12. Rijneveld, A. W., S. Florquin, J. Branger, P. Speelman, S. J. Van Deventer, and T. van der Poll. 2001. TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia. J. Immunol. 167:5240-5246.
13. Schultz, M. J., S. Knapp, S. Florquin, J. Pater, K. Takeda, S. Akira, and T. van der Poll. 2003. Interleukin-18 impairs the pulmonary host response to Pseudomonas aeruginosa. Infect. Immun. 71:1630-1634.
14. Skerrett, S. J., T. R. Martin, E. Y. Chi, J. J. Peschon, K. M. Mohler, and C. B. Wilson. 1999. Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am. J. Physiol. 276:L715-L727.
15. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383-390.
16. Turk, D. C. 1984. The pathogenicity of Haemophilus influenzae. J. Med. Microbiol. 18:1-16.
17. Wieland, C. W., S. Florquin, N. A. Maris, K. Hoebe, B. Beutler, K. Takeda, S. Akira, and T. van der Poll. 2005. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J. Immunol. 175:6042-6049.
18. Wieland, C. W., S. Knapp, S. Florquin, A. F. de Vos, K. Takeda, S. Akira, D. T. Golenbock, A. Verbon, and T. van der Poll. 2004. Non-mannose-capped lipoarabinomannan induces lung inflammation via toll-like receptor 2. Am. J. Respir. Crit. Care Med. 170:1367-1374.
19. Wiersinga, W. J., C. W. Wieland, G. J. van der Windt, A. de Boer, S. Florquin, A. Dondorp, N. P. Day, S. J. Peacock, and T. van der Poll. 2007. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect. Immun. 75:3739-3746.